With news that the Japanese whiskey and beer giant Suntory Holdings has agreed to purchase the maker of the legendary Jim Beam bourbon for $13.6 billion, another chunk of Americana falls into foreign hands. But, in this case, perhaps, ably so.
Suntory ��which makes Yamazaki whiskey and Premium Malt's beer ��totally gets American shtick. It was, after all, among the earliest major Asian marketers to cozy-up to American celebrities to sell stuff in Japan. Way back in the "Rat Pack" heyday of the early 1970s, no less than Sammy Davis Jr., showed up in ads for Suntory brands in Japan.
Even folks who don't have the name Suntory at the tips of their tongues, probably are familiar with actor Bill Murray, whose character in the 2003 film Lost in Translation, so perfectly depicted the image of a fading American actor seeking redemption �� and a few bucks �� overseas. His most famous line from the film: "For relaxing times, make it Suntory time."
10 Best Heal Care Stocks To Own Right Now: Navigant Consulting Inc (NCI)
Navigant Consulting, Inc., incorporated in 1996, is an independent specialty consulting firm. Professional services include dispute, investigative, economic, operational, risk management technology, financial and regulatory advisory solutions. The Company provides companies, legal counsel and governmental agencies facing the challenges of uncertainty, risk, distress and significant change. It provides a range of offerings to its client base. It operates in four segments: Business Consulting Services, Dispute and Investigative Services, Economic Consulting and International Consulting. On July 15, 2011, the Company acquired assets of Ignited Solutions, LLC. In October 2011, the Company acquired Paragon Health, a national physician practice management and consulting firm specializing in Cardiovascular practices. Effective July 9, 2013, the Company acquired The Anson Group LLC.
The Business Consulting Services reporting segment provides strategic, operational, financial, regulatory and technical management consulting services to clients, principally C suite and corporate management, governmental entities and law firms. During the year ended December 31, 2011, the reporting segment consisted of three operating segments, Energy, Healthcare and Other Business Consulting. The Energy and Healthcare business units are defined as operating segments due to their size, importance and organizational reporting relationships. The Energy and Healthcare operating segments provide services to clients in those respective markets and the Other Business Consulting operating segment provides operations advisory, valuation and restructuring services to clients in the financial services and other industries..
The Dispute and Investigative Services reporting segment provides a range of services to clients facing the challenges of disputes, litigation, forensic investigation, discovery and regulatory compliance. The clients of this segment are principally law firms, corporate general counsel and cor! porate boards and government agencies.
The Economic Consulting reporting segment provides economic and financial analyses of legal and business issues principally for law firms, corporations and governmental agencies. Expertise includes areas, such as antitrust, corporate finance and governance, bankruptcy, intellectual property, investment banking, labor market discrimination and compensation, corporate valuation and securities litigation.
The International Consulting reporting segment provides a mix of dispute and business consulting services to clients predominately outside North America. The clients are principally C suite and corporate management, governmental entities and law firms. The clients are principally C suite executives and corporate management, governmental agencies and law firms.
Advisors' Opinion:- [By MONEYMORNING]
In fact, of the 10 companies examined, Navigant Consulting Inc. (NYSE: NCI) is the only one that has received no new contract awards since the GAO's March 31 study cutoff date. (The firm is tasked with data collection and customer outreach.)
In late October, Health and Human Services Secretary Kathleen Sebelius testified under oath to Congress to address the Obamacare website launch disaster. She began with a prepared statement, with comments like "You deserve better," "I apologize," and "I'm accountable to you."
5 Best Asian Stocks To Own Right Now: Penn Virginia Corporation(PVA)
Penn Virginia Corporation, an independent oil and gas company, primarily engages in the exploration and development of natural gas and oil properties in various onshore regions of the United States. The company is involved in the production and sale of natural gas, crude oil, and natural gas liquid products. It primarily focuses on developing the Eagle Ford Shale play in south Texas; and the horizontal Granite Wash play in the Mid-Continent region. The company also drills exploratory wells in the Marcellus Shale play in Pennsylvania; and has interests in the natural gas properties in the Haynesville Shale and Cotton Valley Sands in east Texas, and Selma Chalk in Mississippi. As of December 31, 2011, it had proved natural gas and oil reserves of approximately 883 billion cubic feet of natural gas equivalent; and owned approximately 1.1 million net acres of leasehold and royalty interests. The company sells its products using short-term floating price physical and spot marke t contracts. Penn Virginia Corporation was founded in 1882 and is headquartered in Radnor, Pennsylvania.
Advisors' Opinion:- [By Victor Selva]
Competitors such as Sandridge Energy Inc. (SD), Penn Virginia Corp. (PVA), Newfield Exploration Co. (NFX) also have a negative ROE. An alternative could be Cabot Oil &Gas Corp. (COG), Range Resources Corp. (RRC), SM Energy Co. (SM), Pioneer Natural Resources Co. (PXD) or Whiting Petroleum Corp (WLL), Berry Petroleum Co. (BRY), but for investors searching for a higher ratio, Continental Resources Inc. (CLR) will be the best option.
- [By Ben Levisohn]
Shares of Penn Virgina (PVA) have surged today after the oil & gas explorer had its target price raised to $12 at Howard Weil.
Penn Virginia’s stock has been on the move during the last few weeks, but that’s no reason to bet against it, note Howard Weil’s Brian Corales and David Amoss. They write:
Despite the ~38% move in the stock over the last couple of weeks, PVA has tremendous upside with current assets. The compelling acreage position in the Eagle Ford, where PVA has ~66,000 net acres, should fuel the necessary growth over the next decade. The Company has delineated the acreage block and has 10 years of engineered locations with the potential to almost double that via ~50-acre downspacing, which is the current development plan by both PVA and neighboring Eagle Ford peers. The underlying valuation remains one of the most compelling for onshore operators at just 55% of our NAV and just 3.7x 2014 EBITDA.
Penn Virginia has gained 6.9% to $7.15 at 11:56 p.m. today, while Sanchez Energy (SN) has advanced 5.2% to $29.10, Abraxas Petroleum (AXAS) has risen 2.4% to $2.97 and Gulfport Energy (GPOR) is up 1.3% at $67.31.
5 Best Asian Stocks To Own Right Now: Hudson City Bancorp Inc.(HCBK)
Hudson City Bancorp, Inc. operates as the bank holding company for Hudson City Savings Bank that provides a range of retail banking services. It offers a range of deposit accounts, including passbook and statement savings accounts, interest-bearing transaction accounts, checking accounts, money market accounts, and time deposits, as well as IRA accounts and qualified retirement plans. The company?s loan portfolio primarily comprises one-to four-family first mortgage loans for residential properties; multi-family and commercial mortgage loans; construction loans; and consumer loans, such as fixed-rate second mortgage loans and home equity credit line loans, as well as collateralized passbook loans, overdraft protection loans, automobile loans, and secured and unsecured commercial lines of credit. As of December 31, 2009, it operated 95 branches located in 17 counties throughout the State of New Jersey; 10 branch offices in Westchester County, 9 branch offices in Suffolk Cou nty, 1 branch office each in Putnam and Rockland Counties, and 6 branch offices in Richmond County; and 9 branch offices in Fairfield County, Connecticut. The company was founded in 1868 and is based in Paramus, New Jersey.
Advisors' Opinion:- [By Jon C. Ogg]
The M&T Bank Corp. (NYSE: MTB) and Hudson City Bancorp Inc. (NASDAQ: HCBK) transaction is the only pending deal of 2012 vintage due to various regulatory concerns. MTB currently has 9% short interest outstanding and PACW 15%. Another merger covered is the deal between Provident New York Bancorp (NASDAQ: PBNY) and Sterling Bancorp (NYSE: STL), and the balance are simply too small for us to warrant effort.
- [By Dan Caplinger]
Beyond the Dow, Hudson City Bancorp (NASDAQ: HCBK ) has dropped more than 5% after the bank and its proposed acquirer, M&T Bank (NYSE: MTB ) , said there would be a delay in completing their merger. M&T, which has slipped almost 4%, cited regulatory concerns from the Federal Reserve over its bank secrecy and anti-money-laundering programs. Despite the two banks' plan to extend their agreement until the end of January 2014, they aren't sure the merger will be complete even by then. Shareholders will still vote on the deal later this month, but the delay has to be disconcerting for investors on both sides.
5 Best Asian Stocks To Own Right Now: Actavis Inc (ACT)
Actavis, Inc., formerly Watson Pharmaceuticals, Inc., incorporated on February 1, 1985, is a integrated global specialty pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, branded generic, brand, biosimilar and over-the-counter (OTC) pharmaceutical products. The Company also develops and out-licenses generic pharmaceutical products primarily in Europe through its Medis third-party business. The Company operates in three segments: Actavis Pharma, Actavis Specialty Brands and Anda Distribution. On January 23, 2013, the Company completed the acquisition of Uteron Pharma SA. On October 29, 2012, the Company sold its Rugby OTC pharmaceutical products and trademarks to The Harvard Drug Group, L.L.C. On January 24, 2012, the Company completed the acquisition of Ascent Pharmahealth Ltd.
Actavis Pharma Segment
Actavis Pharma Segment is engaged in the development, manufacturing and sale of generic, branded generic and OTC pharmaceutical products. The Company�� portfolio of generic products includes products it has developed internally and products licensed from and distributed for third parties. The Company sells its generic prescription products primarily under the Watson Laboratories, Watson Pharma and Actavis Pharma labels, and its over-the-counter generic products under private label.
Actavis Specialty Brands Segment
The Company markets a number of branded products to physicians, hospitals, and other markets that it serves. The Company classifies these trademarked products as its brand pharmaceutical products. In April 2012, it launched Gelnique 3% (oxybutynin), a clear, odorless topical gel. Gelnique 3% was obtained through an exclusive licensing agreement with Antares. The Company�� promoted products are Rapaflo, Gelnique, Trelstar, Androderm, Generess Fe and Crinone. The Company�� Actavis Specialty Brands segment also receives other revenues consisting of co-promotion revenue and royaltie! s.
Anda Distribution Segment
The Company Anda Distribution business primarily distributes generic and selected brand pharmaceutical products, vaccines, injectables and over-the-counter medicines to independent pharmacies, alternate care providers (hospitals, nursing homes and mail order pharmacies), pharmacy chains and physicians��offices. In addition, it sells to members of buying groups, which are independent pharmacies that join together to enhance their buying power. As of December 31, 2012, the Company distributes products from its facilities in Weston, Florida, Groveport, Ohio, and Olive Branch, Mississippi, as well as a small volume of product from Puerto Rico.
The Company competes with Teva Pharmaceutical Industries, Ltd., Mylan Inc., Sandoz, Inc, McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc.,
Advisors' Opinion:- [By Rich Smith]
On Friday, shares of branded pharmaceutical manufacturer Warner Chilcott (NASDAQ: WCRX ) jumped 20% in response to rumors that the company was in talks to sell itself to larger rival Actavis (NYSE: ACT ) . Warner also reported steady earnings, where a decline had been expected, and reiterated full-year guidance.
- [By Vera Yuan]
Pacer International, Inc. (PACR) was acquired by XPO Logistics, Inc. which remains in our portfolio. We eliminated our position in specialty pharmaceutical company Actavis PLC (ACT) as the price to intrinsic value relationship narrowed. We originally received shares when Actavis bought portfolio holding Warner Chilcott. We eliminated our position in convenience store distributor Core- Mark Holding Co., Inc.( CORE) as the stock rose almost 40% over the last year and reached our estimate of intrinsic value.
- [By MONEYMORNING.COM]
For its part, Actavis Plc. (NYSE: ACT) is a global pharmaceutical firm taking a dual approach to drugs - it makes both branded and lower-cost generics.
- [By Rebecca McClay]
Finally, Avanir Pharmaceuticals Inc. (Nasdaq: AVNR) is up about 7% today after it settled with Actavis South Atlantic and Actavis Inc. (NYSE: ACT) to resolve pending patent litigation regarding ACT's seeking approval to market generic versions of AVNR's NUEDEXTA capsules. ACT is up about 1%.
No comments:
Post a Comment